Lack of an association between interleukin-6-174G/C polymorphism and circulating interleukin-6 levels in normal population: A meta-analysis

DNA and Cell Biology

Volumn 32, Issue 11, 2013, Pages 654-664

  Huang, Mingyuan ^a   Wang, Lihan ^a   Ma, Hong ^a   Wang, Jianan ^a   Xiang, Meixiang ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

AGE; ARTICLE; CAUCASIAN; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNICITY; GENDER; GENE; GENETIC MODEL; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IL 6 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SENSITIVITY ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM;

CORONARY DISEASE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; INTERLEUKIN-6; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES;

EID: 84885992480     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2013.2148     Document Type: Article

References (42)

1. Basso, F., Lowe, G.D., Rumley, A., McMahon, A.D., and Humphries, S.E. (2002). Interleukin-6-174G>C polymorphism and risk of coronary heart disease in West of Scotland coronary prevention study (WOSCOPS). Arterioscler Thromb Vasc Biol 22, 599-604. (Pubitemid 34408740)
2. Bennet, A.M., Prince, J.A., Fei, G.Z., Lyrenas, L., Huang, Y., Wiman, B., Frostegard, J. and Ud, F. (2003). Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction. Atherosclerosis 171, 359-367. (Pubitemid 37486089)
3. Bittar, M.N., Carey, J.A., Barnard, J., Fildes, J.E., Pravica, V., Yonan, N. and Hutchinson, I.V. (2005). Interleukin 6 G-174C polymorphism influences outcome following coronary revas-cularization surgery. Heart Surg Forum 8, E140-145; discussion E145.
4. Brull, D.J., Montgomery, H.E., Sanders, J., Dhamrait, S., Luong, L., Rumley, A., Lowe, G.D. and Humphries, S.E. (2001). In-terleukin-6 gene-174g>c and-572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 21, 1458-1463. (Pubitemid 34219808)
5. Cardellini, M., Perego, L., D'Adamo, M., Marini, M.A., Procopio, C., Hribal, M.L., Andreozzi, F., Frontoni, S., Giacomelli, M., Paganelli, M., et al. (2005). C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance. Diabetes Care 28, 2007-2012. (Pubitemid 41060976)
6. Cole, S.W., Arevalo, J.M., Takahashi, R., Sloan, E.K., Lutgendorf, S.K., Sood, A.K., Sheridan, J.F. and Seeman, T.E. (2010). Computational identification of gene-social environment interaction at the human IL6 locus. Proc Natl Acad Sci USA 107, 5681-5686.
7. Corella, D., Gonzalez, J.I., Bullo, M., Carrasco, P., Portoles, O., Diez-Espino, J., Covas, M.I., Ruiz-Gutierrez, V., Gomez-Gracia, E., Aros, F., et al. (2009). Polymorphisms cyclooxygenase-2-765G>C and interleukin-6-174G >C are associated with serum inflammation markers in a high cardiovascular risk population and do not modify the response to a Mediterranean diet supplemented with virgin olive oil or nuts. J Nutr 139, 128-134.
8. Danesh, J., Kaptoge, S., Mann, A.G., Sarwar, N., Wood, A., Angleman, S.B., Wensley, F., Higgins, J.P., Lennon, L., Eiriksdottir, G., et al. (2008). Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med 5, e78.
9. Donath, M.Y. and Shoelson, S.E. (2011). Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11, 98-107.
10. Egger, M., Davey, S.G., Schneider, M. and Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629-634. (Pubitemid 27387172)
11. Fernandez-Real, J.M., Broch, M., Vendrell, J., Gutierrez, C., Ca-samitjana, R., Pugeat, M., Richart, C. and Ricart, W. (2000). Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes 49, 517-520. (Pubitemid 30131802)
12. Fernandez-Real, J.M., Broch, M., Vendrell, J., Richart, C. and Ricart, W. (2000). Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. J Clin Endocrinol Metab 85, 1334-1339. (Pubitemid 32269397)
13. Fishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V., Yudkin, J.S., Humphries, S. and Woo, P. (1998). The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102, 1369-1376. (Pubitemid 28467565)
14. Fried, S.K., Bunkin, D.A. and Greenberg, A.S. (1998). Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorti-coid. J Clin Endocrinol Metab 83, 847-850. (Pubitemid 28496456)
15. Gupta, A., Gupta, V., Singh, A.K., Tiwari, S., Agrawal, S., Natu, S.M., Agrawal, C.G., Negi, M.P. and Pant, A.B. (2011). Inter-leukin-6 G-174C gene polymorphism and serum resistin levels in North Indian women: potential risk of metabolic syndrome. Hum Exp Toxicol 30, 1445-1453.
16. Herbert, A., Liu, C., Karamohamed, S., Liu, J., Manning, A., Fox, C.S., Meigs, J.B. and Cupples, L.A. (2006). BMI modifies associations of IL-6 genotypes with insulin resistance: the Fra-mingham Study. Obesity (Silver Spring) 14, 1454-1461. (Pubitemid 46219672)
17. Hingorani, A.D. and Casas, J.P. (2012). The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet 379, 1214-1224.
18. Humphries, S.E., Luong, L.A., Ogg, M.S., Hawe, E. and Miller, G.J. (2001). The interleukin-6-174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 22, 2243-2252. (Pubitemid 34000979)
19. Illig, T., Bongardt, F., Schopfer, A., Muller-Scholze, S., Rath-mann, W., Koenig, W., Thorand, B., Vollmert, C., Holle, R., Kolb, H., et al. (2004). Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G with type 2 diabetes. J Clin Endocrinol Metab 89, 5053-5058. (Pubitemid 39391448)
20. Jones, K.G., Brull, D.J., Brown, L.C., Sian, M., Greenhalgh, R.M., Humphries, S.E. and Powell, J.T. (2001). Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 103, 2260-2265. (Pubitemid 32433715)
21. Kanoni, S., Dedoussis, G.V., Herbein, G., Fulop, T., Varin, A., Jajte, J., Rink, L., Monti, D., Mariani, E., Malavolta, M., et al. (2010). Assessment of gene-nutrient interactions on inflammatory status of the elderly with the use of a zinc diet score-ZINCAGE study. J Nutr Biochem 21, 526-531.
22. Kelberman, D., Hawe, E., Luong, L.A., Mohamed-Ali, V., Lund-man, P., Tornvall, P., Aillaud, M.F., Juhan-Vague, I., Yudkin, J.S., Margaglione, M., et al. (2004). Effect of Interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIF-MECH Study. Thromb Haemost 92, 1122-1128. (Pubitemid 39545538)
23. Kubaszek, A., Pihlajamaki, J., Punnonen, K., Karhapaa, P., Vauhkonen, I. and Laakso, M. (2003). The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity. Diabetes 52, 558-561. (Pubitemid 36173216)
24. Kuo, L.T., Yang, N.I., Cherng, W.J., Verma, S., Hung, M.J., Wang, S.Y., Liu, M.H., Chen, S.Y. and Wang, C.H. (2008). Serum interleukin-6 levels, not genotype, correlate with coronary plaque complexity. Int Heart J 49, 391-402.
25. Liu, Y., Berthier-Schaad, Y., Fallin, M.D., Fink, N.E., Tracy, R.P., Klag, M.J., Smith, M.W. and Coresh, J. (2006). IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort. J Am Soc Nephrol 17, 863-870.
26. Madec, S., Chiarugi, M., Santini, E., Rossi, C., Miccoli, P., Fer-rannini, E. and Solini, A. (2010). Pattern of expression of inflammatory markers in adipose tissue of untreated hypertensive patients. J Hypertens 28, 1459-1465.
27. Moher, D., Cook, D.J., Eastwood, S., Olkin, I., Rennie, D. and Stroup, D.F. (1999). Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 354, 1896-1900.
28. Mohlig, M., Spranger, J., Osterhoff, M., Ristow, M., Pfeiffer, A.F., Schill, T., Schlosser, H.W., Brabant, G. and Schofl, C. (2004). The polycystic ovary syndrome per se is not associated with increased chronic inflammation. Eur J Endocrinol 150, 525-532. (Pubitemid 38584704)
29. Moleres, A., Rendo-Urteaga, T., Azcona, C., Martinez, J.A., Gomez-Martinez, S., Ruiz, J.R., Moreno, L.A., Marcos, A. and Marti, A. (2009). Il6 gene promoter polymorphism (-174G/C) influences the association between fat mass and cardiovascular risk factors. J Physiol Biochem 65, 405-413.
30. Mysliwska, J., Wieckiewicz, J., Hak, L., Siebert, J., Rogowski, J., Szyndler, K. and Mysliwski, A. (2006). Interleukin 6 polymorphism corresponds to the number of severely stenosed coronary arteries. Eur Cytokine Netw 17, 181-188.
31. Mysliwska, J., Zorena, K., Mysliwiec, M., Malinowska, E., Rac-zynska, K. and Balcerska, A. (2009). The-174GG interleukin-6 genotype is protective from retinopathy and nephropathy in juvenile onset type 1 diabetes mellitus. Pediatr Res 66, 341-345.
32. Qi, L., van Dam RM, Meigs, J.B., Manson, J.E., Hunter, D. and Hu, F.B. (2006). Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis. Hum Mol Genet 15, 1914-1920. (Pubitemid 43821781)
33. Ridker, P.M., Rifai, N., Stampfer, M.J. and Hennekens, C.H. (2000). Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101, 1767-1772. (Pubitemid 30213096)
34. Sanderson, S.C., Kumari, M., Brunner, E.J., Miller, M.A., Rum-ley, A., Lowe, G.D., Marmot, M.G. and Humphries, S.E. (2009). Association between IL6 gene variants-174G>C and-572G > C and serum IL-6 levels: interactions with social position in the Whitehall II cohort. Atherosclerosis 204, 459-464.
35. Shen, J., Arnett, D.K., Perez-Martinez, P., Parnell, L.D., Lai, C.Q., Peacock, J.M., Hixson, J.E., Tsai, M.Y., Straka, R.J., Hopkins, P.N., et al. (2008). The effect of IL6-174C/G polymorphism on postprandial triglyceride metabolism in the GOLDN study-boxs. J Lipid Res 49, 1839-1845.
36. Sie, M.P., Mattace-Raso, F.U., Uitterlinden, A.G., Arp, P.P., Hofman, A., Pols, H.A., Hoeks, A.P., Reneman, R.S., Asmar, R., van Duijn CM, et al. (2008). The interleukin-6-174 G/C promoter polymorphism and arterial stiffness; the Rotterdam Study. Vasc Health Risk Manag 4, 863-869.
37. Stephens, J.W., Hurel, S.J., Cooper, J.A., Acharya, J., Miller, G.J. and Humphries, S.E. (2004). A common functional variant in the interleukin-6 gene is associated with increased body mass index in subjects with type 2 diabetes mellitus. Mol Genet Metab 82, 180-186. (Pubitemid 38692557)
38. Terry, C.F., Loukaci, V. and Green, F.R. (2000). Cooperative influence of genetic polymorphisms on interleukin 6 transcrip-tional regulation. J Biol Chem 275, 18138-18144. (Pubitemid 30414764)
39. van Oijen M, Arp, P.P., de Jong FJ, Hofman, A., Koudstaal, P.J., Uitterlinden, A.G. and Breteler, M.M. (2006). Polymorphisms in the interleukin 6 and transforming growth factor beta1 gene and risk of dementia. The Rotterdam Study. Neurosci Lett 402, 113-117.
40. Walston, J.D., Fallin, M.D., Cushman, M., Lange, L., Psaty, B., Jenny, N., Browner, W., Tracy, R., Durda, P. and Reiner, A. (2007). IL-6 gene variation is associated with IL-6 and C-reactive protein levels but not cardiovascular outcomes in the Cardiovascular Health Study. Hum Genet 122, 485-494. (Pubitemid 350148960)
41. Woo, P. and Humphries, S.E. (2013). IL-6 polymorphisms: a useful genetic tool for inflammation research. J Clin Invest 123, 1413-1414.
42. Wypasek, E., Undas, A., Sniezek-Maciejewska, M., Kapelak, B., Plicner, D., Stepien, E. and Sadowski, J. (2010). The increased plasma C-reactive protein and interleukin-6 levels in patients undergoing coronary artery bypass grafting surgery are associated with the interleukin-6-174G>C gene polymorphism. Ann Clin Biochem 47, 343-349.